Showing results (61-70 of 621) with videos related to
Sort By:
Pageof 63
Therapeutic Advances in Neurological Disorders|July 28, 2022
Positive effect of immunomodulatory therapies on disease progression in Huntington's disease? Data from a real-world cohortJannis Achenbach, Carsten Saft, Simon Faissner, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 7, 2014
Interferon-beta affects mitochondrial activity in CD4+ lymphocytes: Implications for mechanism of action in multiple sclerosisAiden Haghikia, Simon Faissner, Derek Pappas, et al.Der Nervenarzt|August 24, 2021
[Immunotherapy and personalized treatment of multiple sclerosis]Ralf A Linker, Ralf GoldNeurology|April 23, 2003
The pathogenesis of CIDP: rationale for treatment with immunomodulatory agentsKlaus V Toyka, Ralf GoldExpert Review of Neurotherapeutics|December 3, 2013
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity guidelinesRalf Gold, Celia Oreja-GuevaraJournal of Neurology|September 26, 2006
Therapy of immune neuropathies with intravenous immunoglobulinsRalf Gold, Bernd C KieseierNeurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 21, 2008
Current and future standards in treatment of myasthenia gravisRalf Gold, Christiane Schneider-GoldCurrent Opinion in Neurology|May 14, 2005
Genomics, proteomics, metabolomics: what is in a word for multiple sclerosis?Saleh M Ibrahim, Ralf GoldCurrent Neurology and Neuroscience Reports|September 25, 2013
Dimethyl fumarate for treatment of multiple sclerosis: mechanism of action, effectiveness, and side effectsRalf A Linker, Ralf GoldCurrent Opinion in Neurology|May 3, 2008
Use of intravenous immunoglobulin and plasma exchange in neurological diseaseRalf A Linker, Ralf GoldPageof 63